Taisho Pharmaceutical Holdings Co., Ltd.

TSE:4581.T

8580 (JPY) • At close April 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) JPY.

202220212020201920182017201620152014201320122011201020092008200720062005
Omzet 301,381268,203282,037288,720261,369280,138279,750289,956290,489295,969285,114271,245268,698258,518256,351249,783242,075271,129
Kosten van de omzet 123,531104,371106,050108,33791,20697,154101,525113,143112,240111,275108,90498,99896,46091,81586,88985,29582,22486,408
Brutowinst 177,850163,832175,987180,383170,163182,984178,225176,813178,249184,694176,210172,247172,238166,703169,462164,488159,851184,721
Brutowinstmarge 0.590.6110.6240.6250.6510.6530.6370.610.6140.6240.6180.6350.6410.6450.6610.6590.660.681
Onderzoek- en ontwikkelingskosten 20,72719,36620,25122,87620,801000000000024,74528,51923,072
Algemene en administratieve kosten 84,64882,31878,37674,49263,123000000000131,52614,94213,08313,906
Verkoop- en marketingkosten 49,45651,40457,39461,55555,027000000000039,09642,30144,724
Verkoop-, algemene en administratieve kosten 134,104133,722135,770136,047118,150000000000131,52654,03855,38458,630
Overige kosten 322-1363351701,1036346066866585918191,4821,2458772,100822736162
Bedrijfskosten 154,831153,088156,021158,923138,951146,007146,260147,935146,273143,009140,873133,833128,154132,017131,526118,666127,153126,303
Bedrijfsresultaat 23,01810,74319,96521,46031,21136,97731,96628,87831,97441,68335,33738,41444,08434,68637,93645,82232,69858,418
Bedrijfsresultaat ratio 0.0760.040.0710.0740.1190.1320.1140.10.110.1410.1240.1420.1640.1340.1480.1830.1350.215
Totaal overige inkomsten en kosten netto 6,47910,6543,0108,85033,27011,0939,9906,9318,1879,6327,8714,5788,9221,104-11,177-4,832-3,702-107
Inkomen voor belasting 29,49821,39822,97630,31164,48448,07041,95635,80940,16251,31643,20842,99253,00635,79026,75940,99028,99658,311
Inkomen voor belasting ratio 0.0980.080.0810.1050.2470.1720.150.1230.1380.1730.1520.1580.1970.1380.1040.1640.120.215
Belastingkosten 8,1966,4487,7828,42314,65814,70111,75011,92714,10217,30515,63017,74017,21215,18016,81815,78213,79522,517
Nettowinst 18,99713,12213,31620,17248,59331,67928,78122,47324,52832,69226,32024,35734,89219,4858,81525,00415,42035,884
Nettowinstmarge 0.0630.0490.0470.070.1860.1130.1030.0780.0840.110.0920.090.130.0750.0340.10.0640.132
WPA (Winst Per Aandeel) 231.72161.12166.83252.73608.8396.54360.18277.75302.57403.18325.26296.2416.33226.6100.03280.03168.47387.27
Verwaterde WPA 231.42160.93166.63252.44608.22396.2359.92277.59302.42403.07325.22296.2416.33226.6100.03280.03168.47387.27
EBITDA 55,28641,65648,19241,82452,14153,52349,70749,24952,51563,63456,24358,28966,54048,51264,54263,39648,52183,096
EBITDA ratio 0.1830.1550.1710.1450.1990.1910.1780.170.1810.2150.1970.2150.2480.1880.2520.2540.20.306